NEW YORK, Dec. 10, 2025 — Because the World Well being Group warns that synthetic intelligence in healthcare could also be advancing sooner than security requirements can sustain with, a physician-CEO says the dialog is lacking a crucial level: clinically constructed and clinically ruled AI might now be one of the vital highly effective life-saving instruments drugs has.
“The WHO is completely proper to focus on the dangers that include the speedy rise of AI in healthcare,” mentioned Dr. Essam Hamza, CEO of Rocket Physician AI Inc. “Too many techniques depend on opaque algorithms and the potential of hallucinations, with out the authorized or scientific safeguards sufferers and well being employees deserve. At Rocket Physician AI, we’ve taken a essentially completely different method.”
Rocket Physician AI is positioning its physician-built International Library of Drugs (GLM) and suite of AI-driven options because the counterpoint to opaque, hallucination-prone AI techniques presently prompting world concern. As demand surges for reliable scientific instruments that cut back administrative load and strengthen accuracy in diagnoses, the corporate believes its methodology, constructed over greater than a decade by a whole bunch of clinicians, is the mannequin the business wants.
“We use giant language fashions solely as a presentation layer — by no means because the supply of scientific judgment,” Dr. Hamza mentioned. “The scientific pathways, differential diagnoses and suggestions generated inside GLM are grounded in vetted, evidence-based medical data.
“This design ensures that AI is used to help, not substitute, healthcare professionals — strengthening security, bettering decision-making and finally delivering higher outcomes for sufferers,” he continued. “Innovation in healthcare should transfer quick, but it surely should additionally transfer safely. Our dedication is to do each.”
Rocket Physician AI Inc. delivers physician-built, AI-powered options designed to make high-quality healthcare accessible all through your complete affected person journey. A cornerstone of the corporate’s proprietary expertise is the International Library of Drugs (GLM), a clinically validated determination help system developed with enter from a whole bunch of physicians worldwide.
Alongside the GLM is Rocket Physician Inc. and its AI-powered digital well being platform and market that has empowered over 300 MDs to ship greater than 700,000 affected person visits. By decreasing administrative burdens and restoring autonomy to clinicians, Rocket Physician AI expands affected person entry whereas bettering diagnostic consistency and supporting underserved communities in Canada and america.
Dr. Essam Hamza is a doctor, entrepreneur, expertise innovator, and CEO and Director of Rocket Physician AI Inc. with greater than twenty years of expertise advancing digital healthcare options. He earned his Physician of Drugs from the College of Alberta.
Dr. Hamza based HealthVue Ventures Ltd. in 2005, constructing a community of superior medical clinics that served over 100,000 sufferers. In 2018, he based CloudMD, a pioneer in digital healthcare expertise, and served as CEO and Director till 2022, guiding its progress right into a publicly traded firm on the TSX Enterprise Alternate with income rising from underneath $4 million to over $100 million.
Dr. Hamza has additionally held management and advisory roles throughout the healthcare and biotechnology sectors, together with Unbiased Director at quite a lot of publicly traded corporations. With in depth capital markets expertise, he has efficiently scaled and financed a number of ventures on the intersection of medication and innovation.
